Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
Arthritic pathologies are a major cause of morbidity within the western world, with rheumatoid arthritis affecting approximately 1% of adults. This review highlights the therapeutic potential of naturally occurring hormones and their peptides, in both arthritic models of disease and patients. The ar...
Saved in:
Main Authors: | S. J. Getting, M. Kaneva, Y. Bhadresa, D. Renshaw, Giovanna Leoni, H. B. Patel, M. J. P. Kerrigan, I. C. Locke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2009.163 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticoid and Melanocortins: Special Issue
by: Stephen J. Getting
Published: (2007-01-01) -
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy
by: S. Rossi, et al.
Published: (2016-01-01) -
Antimicrobial Properties of α-MSH and Related Synthetic Melanocortins
by: A. Catania, et al.
Published: (2006-01-01) -
Pharmacological and Pharmacodynamic Implications of Nonsteroidal Anti-Inflammatory Drug Therapy in Elderly Arthritic Patients
by: W Watson Buchanan
Published: (1990-01-01) -
Food intake regulation during pregnancy and lactation in mice with reduced activity of the melanocortin system
by: E. N. Makarova, et al.
Published: (2016-05-01)